Skip to main content
Archived articles

Health

Bloomberg invests $50M to address opioid epidemic
Published Nov 30, 2018
New CDC figures show recent decline in U.S. life expectancy tied to record number of drug and opioid overdose deaths
American health
Connections that matter
Published Nov 29, 2018
Researchers outline a public health plan to reengage disconnected youth, young adults age 16 to 24 who are both out of school and out of work
Ten from Hopkins make '30 Under 30' list
Published Nov 28, 2018
The list, compiled by 'Forbes,' recognizes young people who have become leaders in their fields
Community
Hopkins to expand support for survivors of violence in Baltimore
Published Nov 20, 2018
$1.6M grant from Stavros Niarchos Foundation comes in response to community's request for more support, services that promote healing
Interdisciplinary research
Cardiologists, engineers collaborate
Published Nov 19, 2018
New center will oversee clinical trials of biomedical interventions for treating heart disease developed at Johns Hopkins
Health care
Patients with untreated hearing loss incur higher health care costs over time
Published Nov 16, 2018
Older adults with untreated hearing loss generated 46 percent more in total health care costs over 10 years compared to those who don't have hearing loss
U.S. health
Experts at summit examine public health challenges facing U.S.
Published Nov 16, 2018
Speakers at inaugural Bloomberg American Health Summit include Michael R. Bloomberg, Arne Duncan, Walter Isaacson, Leana Wen, Tom Wolf, and others
Heart health
Western diet and lifestyle raises blood pressure
Published Nov 15, 2018
Study examined two South American tribes—one that has little Western contact and one that has been exposed to Western diet and lifestyle
Studies to explore immune responses to flu shots
Published Nov 6, 2018
Johns Hopkins gets $8M NIH grant to look at differences in how men, women respond to flu shots
Cell engineering
Cell death pathway tied to Parkinson's
Published Nov 5, 2018
Understanding the pathway for nerve cell degradation in Parkinson's disease could unlock new avenues for treating the disease